×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
WGS – genedx holdings corp. - class a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
WGS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/22
04:05 pm
wgs
GeneDx to Participate in Upcoming Investor Conference
Low
Report
GeneDx to Participate in Upcoming Investor Conference
11/19
08:30 am
wgs
GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover
Low
Report
GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover
11/18
08:30 am
wgs
GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary
Medium
Report
GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary
11/16
05:07 am
wgs
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year [Yahoo! Finance]
Medium
Report
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year [Yahoo! Finance]
11/7
04:35 pm
wgs
New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields
Medium
Report
New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields
11/4
04:35 pm
wgs
GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
Low
Report
GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
10/30
01:03 pm
wgs
GeneDx Holdings Corp. (NASDAQ: WGS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $54.00 to $70.00. They now have a "neutral" rating on the stock.
Low
Report
GeneDx Holdings Corp. (NASDAQ: WGS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $54.00 to $70.00. They now have a "neutral" rating on the stock.
10/30
11:28 am
wgs
GeneDx Holdings Corp. (NASDAQ: WGS) had its price target raised by analysts at Wells Fargo & Company from $34.00 to $75.00. They now have an "equal weight" rating on the stock.
Low
Report
GeneDx Holdings Corp. (NASDAQ: WGS) had its price target raised by analysts at Wells Fargo & Company from $34.00 to $75.00. They now have an "equal weight" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
10/29/2024
08:00 am
WGS
genedx holdings corp. - class a
MISS
Report
49.5%
genedx holdings corp. - class a
7/30/2024
04:05 pm
WGS
genedx holdings corp. - class a
MISS
Report
8.6%
genedx holdings corp. - class a
4/29/2024
04:05 pm
WGS
genedx holdings corp. - class a
MISS
Report
55.2%
genedx holdings corp. - class a
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/21
08:24 pm
wgs
Form 4/A GeneDx Holdings Corp. For: Oct 15 Filed by: RUCH JOSHUA
Medium
Report
Form 4/A GeneDx Holdings Corp. For: Oct 15 Filed by: RUCH JOSHUA
11/21
08:22 pm
wgs
Form 4 GeneDx Holdings Corp. For: Nov 19 Filed by: Ryan Jason
Medium
Report
Form 4 GeneDx Holdings Corp. For: Nov 19 Filed by: Ryan Jason
11/21
06:15 pm
wgs
Form 144 GeneDx Holdings Corp. Filed by: Feeley Kevin
Medium
Report
Form 144 GeneDx Holdings Corp. Filed by: Feeley Kevin
11/20
09:37 pm
wgs
Form SC 13D/A GeneDx Holdings Corp. Filed by: OPKO HEALTH, INC.
Medium
Report
Form SC 13D/A GeneDx Holdings Corp. Filed by: OPKO HEALTH, INC.
11/19
08:01 pm
wgs
Form SC 13D/A GeneDx Holdings Corp. Filed by: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Low
Report
Form SC 13D/A GeneDx Holdings Corp. Filed by: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
11/19
08:01 pm
wgs
Form 4 GeneDx Holdings Corp. For: Nov 15 Filed by: MOUNT SINAI HEALTH SYSTEM, INC.
Low
Report
Form 4 GeneDx Holdings Corp. For: Nov 15 Filed by: MOUNT SINAI HEALTH SYSTEM, INC.
11/19
07:06 pm
wgs
Form 4 GeneDx Holdings Corp. For: Nov 15 Filed by: Stueland Katherine
Low
Report
Form 4 GeneDx Holdings Corp. For: Nov 15 Filed by: Stueland Katherine
11/19
05:11 pm
wgs
Form 144 GeneDx Holdings Corp. Filed by: Ryan Jason
Low
Report
Form 144 GeneDx Holdings Corp. Filed by: Ryan Jason
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: